MIRATI THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 1995-12-13
- Employees
- 593
- Market Cap
- -
- Website
- http://www.mirati.com
FDA Grants Accelerated Approval to Adagrasib Plus Cetuximab for KRAS G12C-Mutated Advanced Colorectal Cancer
The FDA has granted accelerated approval to adagrasib plus cetuximab for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer who have received prior chemotherapy.